<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(1)</volume><submitter>de Oliveira Souza NV</submitter><funding>Bee Foundation</funding><pubmed_abstract>Reliable assessment of prognosis after aneurysmal subarachnoid hemorrhage (SAH) is essential to inform clinical decision-making and prevent premature assumptions of poor outcome. The enhanced SAH (eSAH) score combines three routinely available variables-age, Glasgow Coma Scale (GCS), and subarachnoid hemorrhage blood volume (SAHV)-to provide an objective framework for early outcome stratification. SAHV is estimated using the ABC/2-derived ellipsoid method applied across five major cisternal compartments on non-contrast CT. While the eSAH score has shown promise in initial derivation studies, its external performance and calibration have not yet been validated across diverse healthcare settings. We conducted a retrospective cohort study using consecutive data from two high-volume tertiary c</pubmed_abstract><journal>Scientific reports</journal><pagination>4218</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12858902</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>External multicenter validation of the eSAH score for predicting outcomes after subarachnoid hemorrhage.</pubmed_title><pmcid>PMC12858902</pmcid><pubmed_authors>Gutierrez-Aguirre SF</pubmed_authors><pubmed_authors>Marques IP</pubmed_authors><pubmed_authors>Sharma R</pubmed_authors><pubmed_authors>Neeraj N</pubmed_authors><pubmed_authors>Aghaebrahim A</pubmed_authors><pubmed_authors>de Toledo OF</pubmed_authors><pubmed_authors>Silva GS</pubmed_authors><pubmed_authors>de Oliveira Souza NV</pubmed_authors><pubmed_authors>Sauvageau E</pubmed_authors><pubmed_authors>Hanel RA</pubmed_authors><pubmed_authors>Montserrat LV</pubmed_authors><pubmed_authors>Freeman WD</pubmed_authors><pubmed_authors>Chaddad Neto F</pubmed_authors></additional><is_claimable>false</is_claimable><name>External multicenter validation of the eSAH score for predicting outcomes after subarachnoid hemorrhage.</name><description>Reliable assessment of prognosis after aneurysmal subarachnoid hemorrhage (SAH) is essential to inform clinical decision-making and prevent premature assumptions of poor outcome. The enhanced SAH (eSAH) score combines three routinely available variables-age, Glasgow Coma Scale (GCS), and subarachnoid hemorrhage blood volume (SAHV)-to provide an objective framework for early outcome stratification. SAHV is estimated using the ABC/2-derived ellipsoid method applied across five major cisternal compartments on non-contrast CT. While the eSAH score has shown promise in initial derivation studies, its external performance and calibration have not yet been validated across diverse healthcare settings. We conducted a retrospective cohort study using consecutive data from two high-volume tertiary c</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-15T06:27:33.807Z</modification><creation>2026-06-15T03:08:35.492Z</creation></dates><accession>S-EPMC12858902</accession><cross_references><pubmed>41476130</pubmed><doi>10.1038/s41598-025-34326-3</doi></cross_references></HashMap>